Robert Mittendorff, MD, General Partner and Head of Healthcare at B Capital
Global multi-stage investment firm B Capital has closed its inaugural healthcare fund.
In conjunction with the VC firm’s third fund, B Capital Healthcare Fund I allocates over US$500 million to opportunities across the healthcare sector, from digital health to biotech.
The fund will target category-defining companies building breakthrough products and solutions and shaping the future of healthcare.
Also Read: B Capital launches US$415M fund; to expand investment activity in India, Indonesia
“We are witnessing unprecedented innovation across the healthcare landscape,” said Robert Mittendorff, MD, General Partner and Head of Healthcare at B Capital. “Technological advancements in biology, AI, and automation are transforming the industry, with business models seeing the convergence of traditional players in novel ways. This moment presents a unique opportunity for the fund to leverage our dedicated healthcare capital and active investment strategy to find and support companies advancing the healthcare sector.”
The current B Capital global healthcare portfolio includes over 20 companies in the US, Asia and Europe, spanning early venture to late growth venture across healthtech, digital health, biotech, and medtech.
In January 2023, the VC firm announced the close of Growth Fund III and affiliated funds with aggregate capital commitments of approximately US$2.1 billion. With these closes, B Capital’s total assets under management are approximately US$6.3 billion.
—
Echelon Asia Summit 2023 brings together APAC’s leading startups, corporates, policymakers, industry leaders, and investors to Singapore this June 14-15. Learn more and get tickets here. Echelon also features the TOP100 stage, where startups can pitch to 5000+ delegates, among other benefits like a chance to connect with investors, visibility through e27 platform, and other prizes. Join TOP100 here.
The post B Capital closes inaugural US$500M healthcare fund appeared first on e27.